Page last updated: 2024-10-27

fluorouracil and Carcinoma, Basal Cell, Pigmented

fluorouracil has been researched along with Carcinoma, Basal Cell, Pigmented in 250 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"We identified 5700 subjects who filled prescriptions for 5-fluorouracil or imiquimod for treatment of actinic keratosis in 2007."7.91Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study. ( Asgari, MM; Chren, MM; Friedman, GD; Neugebauer, R; Sokil, M; Su, KA; Zhu, Z, 2019)
"The authors previously reported the safety and short-term efficacy of ablative fractional laser (AFXL)-assisted delivery of topical fluorouracil in the treatment of superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis)."7.83Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study. ( Gan, SD; Hsu, SH; Konnikov, N; Liang, CA; Nguyen, BT, 2016)
"An 85-year-old woman, with known stable angina pectoris, was prescribed 5-fluorouracil cream to treat a small basal cell carcinoma on the forehead."7.69Myocardial ischemia induced by topical use of 5-fluorouracil. ( Gotsman, MS; Gurewich, J; Rozenman, Y, 1995)
"We describe the successful treatment of porokeratosis of Mibelli of the left calf in an 83-year-old man with topical 5 percent imiquimod and topical 5 percent 5-fluorouracil."5.36Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. ( LeLeux, TM; Orengo, I; Rosen, T; Venkatarajan, S; Yang, D, 2010)
"A 58-year-old man with basal cell nevus syndrome had variously sized basal cell epitheliomas (BCEs), mostly of the superficial type, on his chest, back, and lumbar areas."5.29Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome. ( Nishimura, M; Otake, N; Tsuji, T, 1993)
"A single patient with basal cell nevus syndrome is presented."5.27Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene. ( Hazen, PG; Taub, SJ, 1984)
"The relation between the induction of delayed hypersensitivity reactions to 5-FU following treatment with topical 5-FU and the cure rate for cutaneous neoplasms showed a trend toward correlation."5.25Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers. ( Ichinose, H; Krementz, ET; Litwin, MS; Mansell, PW, 1975)
" Keratoacanthomas had high cure rates with intralesional agents: 98% for 5FU, 91% for methotrexate, 100% for bleomycin, 100% for IFN alpha (α)-2, 83% for IFN α-2a, and 100% for IFN α-2b."4.89Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons. ( Chitwood, K; Cohen, G; Etzkorn, J, 2013)
"We identified 5700 subjects who filled prescriptions for 5-fluorouracil or imiquimod for treatment of actinic keratosis in 2007."3.91Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study. ( Asgari, MM; Chren, MM; Friedman, GD; Neugebauer, R; Sokil, M; Su, KA; Zhu, Z, 2019)
"The authors previously reported the safety and short-term efficacy of ablative fractional laser (AFXL)-assisted delivery of topical fluorouracil in the treatment of superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis)."3.83Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study. ( Gan, SD; Hsu, SH; Konnikov, N; Liang, CA; Nguyen, BT, 2016)
"An 85-year-old woman, with known stable angina pectoris, was prescribed 5-fluorouracil cream to treat a small basal cell carcinoma on the forehead."3.69Myocardial ischemia induced by topical use of 5-fluorouracil. ( Gotsman, MS; Gurewich, J; Rozenman, Y, 1995)
"Successful management of keratoacanthomas and basal-cell epitheliomas by intralesional injections of 5-fluorouracil is reported."3.66Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU). ( Kurtis, B; Rosen, T, 1980)
"15 patients with superficial basaliomas or premalignant epithelial neoplastic disorders (actinic keratosis, leukoplakia, Bowen's disease) were treated locally over three weeks with retinoic acid (RA) alone or in combination with 5-fluorouracil (5-FU)."3.66[Vitamin A acid for the topical management of epithelial neoplasms. Combination with 5-fluorouracil]. ( Kurka, M; Orfanos, CE; Pullmann, H, 1978)
"Treatment with fluorouracil, trichloroacetic acid, or carbon dioxide laser resulted in an 83% to 92% reduction in AKs (P< or =."2.72Facial resurfacing for nonmelanoma skin cancer prophylaxis. ( Cooper, ZA; Hantash, BM; Koch, RJ; Rehmus, WE; Stewart, DB; Swetter, SM, 2006)
"Skin cancer is a broad term used to describe a number of different malignant indications of the skin."2.66Topical treatments for skin cancer. ( Boyle, GM; Cullen, JK; Parsons, PG; Simmons, JL, 2020)
"Chemoprevention of nonmelanoma skin cancer should be considered in patients likely to develop numerous, invasive, or metastatic nonmelanoma skin cancers."2.61Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer. ( Council, ML; Nemer, KM, 2019)
"Nonmelanoma skin cancer (NMSC) is the most common cancer in patients and includes basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)."2.53Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies. ( Cherpelis, B; Rudnick, EW; Thareja, S, 2016)
"Nonmelanoma skin cancer, which encompasses basal cell and squamous cell carcinoma, is the most common cancer in the United States."2.48Diagnosis and treatment of Basal cell and squamous cell carcinoma. ( Firnhaber, JM, 2012)
"With regard to squamous cell carcinoma, treatment with 5-fluorouracil, methotrexate, interferon, and bleomycin are reviewed."2.47Intralesional agents in the management of cutaneous malignancy: a review. ( Good, LM; High, WA; Miller, MD, 2011)
"An updated review of management of nevoid basal cell carcinoma syndrome (NBCCS) is presented."2.44Nevoid basal cell carcinoma syndrome (Gorlin syndrome): updated review of minimally invasive treatments. ( Mitropoulos, P; Norman, R, 2008)
"The ability to manage non-melanoma skin cancers and pre-malignant lesions with topical pharmacologic agents is highly compelling."2.42Topical treatment strategies for non-melanoma skin cancer and precursor lesions. ( Fein, H; McGillis, ST, 2004)
"An integrated program of skin cancer awareness, sun protection, and prophylactic approaches is critical."2.41Nonmelanoma skin cancer. ( Ho, DQ; Nguyen, TH, 2002)
"Non-melanoma skin cancer (NMSC), which includes both Bowen's disease (BD) and superficial basal cell carcinoma (sBCC), is the most commonly diagnosed cancer in Canada."1.91Cryosurgery and 5-Fluorouracil Combination Therapy for Treatment of Bowen's Disease and Superficial Basal Cell Carcinoma. ( Nazarali, S; Sajic, D, 2023)
"AFL-assisted cisplatin + 5-FU in double sessions represents an acceptable and safe treatment strategy for low-risk sBCC, while clearance rates following single treatment or for nBCC seem inferior."1.72Efficacy and safety of laser-assisted combination chemotherapy: A follow-up study of treatment with 5-fluorouracil and cisplatin for basal cell carcinoma. ( Fredman, G; Haedersdal, M; Hendel, K; Togsverd-Bo, K; Wenande, E, 2022)
"Non-melanoma skin cancer (NMSC) is the most common malignancy worldwide, with rising incidence in the recent years."1.72In vitro 5-Fluorouracil resistance produces enhanced photodynamic therapy damage in SCC and tumor resistance in BCC. ( Gilaberte, Y; González, S; Gutiérrez-Pérez, M; Juarranz, Á; Nicolás-Morala, J; Portillo-Esnaola, M; Terrén, S, 2022)
" It provides a promising long-term relief with a tolerable side-effect profile."1.72Long-term efficacy and safety of imiquimod 5% and fluorouracil 1% creams in medical monotherapy of complex eyelid basal cell carcinomas. ( Gupta, P; Kaur, M; Mehta Grewal, A; Sharma, M; Singh, H; Singh, M; Zadeng, Z, 2022)
"Mitomycin C was more effective in inducing the apoptosis of basal cell carcinoma than 5-fluorouracil and their combination."1.62Optimizing the effective doses of mitomycin C, 5-fluorouracil, and their combination on cultivated basal cell carcinoma. ( Aletaha, M; Balagholi, S; Dabbaghi, R; Kanavi, MR; Karami, S; Nakhaie, PA, 2021)
"When treating invasive basal cell carcinoma (BCC) with Mohs micrographic surgery (MMS), including infiltrative and nodular subtypes, the goal is complete surgical removal of the tumor."1.56Topical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery. ( Housewright, C; Pederson, H; Staples, CJ, 2020)
"5-fluorouracil (5-FU) is a cytostatic drug associated with antimetabolite effects and already approved as monotherapy for superficial BCCs treatment."1.51Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solution. ( Bianchi, L; Campione, E; Diluvio, L; Lanna, C; Lozzi, F; Palumbo, V, 2019)
"Superficial basal cell carcinoma is a type of keratinocyte carcinoma that has increasing incidence and substantial morbidity."1.48Comparing Topical Treatments for Basal Cell Carcinoma. ( Shaw, FM; Weinstock, MA, 2018)
"Toxicity was acceptable, with grade 3 renal failure (n=1) and grade 3 or 4 myelotoxicity (n=2)."1.43Weekly Multi-agent Chemotherapy (CMF-b) for Advanced Non-melanoma Skin Cancer. ( Dietrich, PY; Espeli, V; Hottinger, AF; Modarressi, A; Ruegg, E, 2016)
"The incidence of non-melanoma skin cancer (NMSC), including actinic keratosis (AK), squamous cell carcinoma (SCC), Bowen's Disease (BD) and basal cell carcinoma (BCC), is increasing."1.42Field cancerization: from molecular basis to selective field-directed management of actinic keratosis. ( Philipp-Dormston, WG, 2015)
"These activities compared with those in squamous cell carcinoma."1.36[Four resected cases with basaloid carcinoma of esophagus--comparison of 5-FU-related enzymes (thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), orotate phosphoribosyl transferase (OPRT)) between basaloid carcinoma and squamous cell carcin ( Fujiwara, Y; Morimura, K; Takemura, M; Yoshida, K, 2010)
"We describe the successful treatment of porokeratosis of Mibelli of the left calf in an 83-year-old man with topical 5 percent imiquimod and topical 5 percent 5-fluorouracil."1.36Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. ( LeLeux, TM; Orengo, I; Rosen, T; Venkatarajan, S; Yang, D, 2010)
"Non-melanoma skin cancers, such as squamous cell carcinoma and basal cell carcinoma, also represent sun-related conditions that require early and aggressive treatment."1.36Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments. ( Goldsmith, A; Han, A; Marmur, ES; Penrose, C, 2010)
"Twenty-five squamous cell carcinomas, 1 melanoma, 2 basocellular carcinomas and 2 adenoid cystic carcinomas were treated."1.33[The outcome of treatments for carcinoma of the external auditory canal]. ( Delalande, C; Dumas, G; Lavieille, JP; Reyt, E; Righini, Ch; Schmerber, S; Soriano, E, 2005)
"A 58-year-old man with basal cell nevus syndrome had variously sized basal cell epitheliomas (BCEs), mostly of the superficial type, on his chest, back, and lumbar areas."1.29Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome. ( Nishimura, M; Otake, N; Tsuji, T, 1993)
"A single patient with basal cell nevus syndrome is presented."1.27Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene. ( Hazen, PG; Taub, SJ, 1984)
"To improve the results, we have treated the squamous cell carcinomas with topical 5-fluorouracil to obtain sensitization and shrinkage of the tumor before resection."1.27Topical 5-fluorouracil in treatment of carcinoma of nasal floor and nasal alae. ( Marks, MW; Ryan, RF, 1988)
"The relation between the induction of delayed hypersensitivity reactions to 5-FU following treatment with topical 5-FU and the cure rate for cutaneous neoplasms showed a trend toward correlation."1.25Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers. ( Ichinose, H; Krementz, ET; Litwin, MS; Mansell, PW, 1975)

Research

Studies (250)

TimeframeStudies, this research(%)All Research%
pre-1990138 (55.20)18.7374
1990's10 (4.00)18.2507
2000's20 (8.00)29.6817
2010's64 (25.60)24.3611
2020's18 (7.20)2.80

Authors

AuthorsStudies
Neale, H1
Michelon, M1
Jacob, S1
Pinkston, M1
Ukaegbu, R1
Zamor, W1
Morrison, E1
Deng, A1
Levin, NA1
Fredman, G1
Wenande, E2
Hendel, K2
Togsverd-Bo, K2
Haedersdal, M2
Nicolás-Morala, J1
Portillo-Esnaola, M1
Terrén, S1
Gutiérrez-Pérez, M1
Gilaberte, Y1
González, S1
Juarranz, Á1
Gil-Lianes, J1
Morgado-Carrasco, D1
Algarin, YA1
Jambusaria-Pahlajani, A2
Ruiz, E1
Patel, VA2
Yu, Y1
Zhang, G1
Fu, S1
Krieter, M1
Schultz, E1
Nazarali, S1
Sajic, D1
Collins, A1
Savas, J1
Doerfler, L1
Cullen, JK1
Simmons, JL1
Parsons, PG1
Boyle, GM1
Cornejo, CM1
Willenbrink, TJ1
Schmults, CD1
Arron, ST2
Ruiz, ES2
Pederson, H1
Staples, CJ1
Housewright, C1
Gilchrest, BA1
Mogensen, M1
Bagger, C1
Mårtensson, NL1
Persson, DP1
Lerche, CM1
Husted, S1
Janfelt, C1
Anderson, RR1
Maghfour, J1
Kuraitis, D1
Murina, A1
Balagholi, S1
Aletaha, M1
Kanavi, MR1
Karami, S1
Dabbaghi, R1
Nakhaie, PA1
Nahm, WJ1
Shen, J1
Zito, PM1
Gonzalez, AM1
Nagrani, N1
Moore, K1
Badiavas, EV1
Kirsner, RS1
Nichols, AJ1
Means, AD3
Leader, NF3
Siegel, JA3
Walker, JL1
Pomerantz, H1
Beatson, M3
Weinstock, MA7
Singh, M1
Mehta Grewal, A1
Singh, H1
Sharma, M1
Kaur, M1
Gupta, P1
Zadeng, Z1
Ariza, S1
Espinosa, S1
Naranjo, M1
Klinghammer, K1
Otto, R1
Raguse, JD1
Albers, AE1
Tinhofer, I1
Fichtner, I1
Leser, U1
Keilholz, U1
Hoffmann, J1
Essers, BAB3
Arits, AH5
Hendriks, MR1
Mosterd, K9
Kelleners-Smeets, NW6
Jansen, MHE3
Arits, AHMM4
Roozeboom, MH5
Sommer, A3
van Pelt, HPA1
Quaedvlieg, PJF2
Steijlen, PM3
Nelemans, PJ7
Kelleners-Smeets, NWJ4
Thwin, SS1
Marcolivio, K1
Shaw, FM2
Hogan, D1
Eilers, D1
Swetter, SM2
Chen, SC1
Jacob, SE1
Warshaw, EM1
Stricklin, GP1
Dellavalle, RP1
Sidhu-Malik, N1
Konnikov, N3
Werth, VP1
Keri, JE1
Robinson-Bostom, L2
Ringer, RJ1
Lew, RA1
Ferguson, R1
DiGiovanna, JJ2
Huang, GD1
Yoon, J1
Phibbs, CS1
Chow, A1
Koekelkoren, FHJ1
Neal, DE1
Smith, RJ1
Aberbigbe, O1
Etzkorn, JR1
Milosevic, M1
Lazarevic, M1
Toljic, B1
Simonovic, J1
Trisic, D1
Nikolic, N1
Petrovic, M1
Milasin, J1
Neugebauer, R1
Su, KA1
Zhu, Z1
Sokil, M1
Chren, MM2
Friedman, GD1
Asgari, MM1
Basset-Seguin, N1
van Delft, LCJ1
Hamid, MA1
Rosenberg, AR1
Tabacchi, M1
Ngo, KH1
Wallendorf, M1
Rosman, IS1
Cornelius, LA1
Demehri, S1
Diluvio, L1
Lanna, C1
Lozzi, F1
Palumbo, V1
Bianchi, L1
Campione, E1
Nemer, KM1
Council, ML1
Lyons, AB1
Mitchell, DA1
Moy, RL1
Dummer, R2
Essers, BA2
Spoorenberg, E2
De Rooij, MJ1
van Pelt, HP1
Quaedvlieg, PJ1
Krekels, GA1
van Neer, PA1
Rijzewijk, JJ1
van Geest, AJ1
Apalla, Z1
Lallas, A1
Sotiriou, E1
Ioannides, D1
Arits, A2
Chitwood, K1
Etzkorn, J1
Cohen, G1
Xiong, MY1
Korgavkar, K1
Schulze Schwering, M1
Schwering, MS1
Chagaluka, G1
Molyneux, E1
Nelemans, P2
Konda, S1
O'Bryan, KW1
Ratner, D1
Goddard, L1
Mollet, T1
Blalock, T1
Gibbs, S1
Davis, T1
Wang, H1
Xu, Y1
Shi, J1
Gao, X1
Geng, L1
Philipp-Dormston, WG1
Lecluse, LL1
Spuls, PI1
Kelleners-Smeets, N1
Nijsten, T1
Klein, E13
Stoll, HL5
Milgrom, H5
Traenkle, HL3
Graham, S2
Helm, F5
Poulalhon, N1
Dalle, S1
Balme, B1
Thomas, L1
Nguyen, BT2
Gan, SD2
Liang, CA2
Knackstedt, TJ1
Quitadamo, M1
Badea, G1
Lacatusu, I1
Ott, C1
Badea, N1
Grafu, I1
Meghea, A1
van Kleef, L1
Winnepenninckx, VJ1
van Marion, AM1
Cohen, JL1
Friedman, A1
Rudnick, EW1
Thareja, S1
Cherpelis, B1
Wiznia, LE1
Federman, DG1
de Rooij, MJM1
Espeli, V1
Ruegg, E1
Hottinger, AF1
Modarressi, A1
Dietrich, PY1
Hsu, SH1
Naik, MP1
Mehta, A1
Abrol, S1
Kumar, S1
Gupta, VS1
Moore, AY1
Love, WE1
Bernhard, JD1
Bordeaux, JS1
Good, LM1
Miller, MD1
High, WA1
Micali, G1
Lacarrubba, F1
Dinotta, F1
Massimino, D1
Nasca, MR1
Kirby, JS1
Miller, CJ1
Han, A1
Penrose, C1
Goldsmith, A1
Marmur, ES1
Has, C1
Burger, B1
Volz, A1
Kohlhase, J1
Bruckner-Tuderman, L1
Itin, P1
Aguayo-Leiva, IR1
Ríos-Buceta, L1
Jaén-Olasolo, P1
Takemura, M1
Morimura, K1
Yoshida, K1
Fujiwara, Y1
Vollebergh, MA1
Lips, EH1
Nederlof, PM1
Wessels, LFA1
Schmidt, MK1
van Beers, EH1
Cornelissen, S1
Holtkamp, M1
Froklage, FE1
de Vries, EGE1
Schrama, JG1
Wesseling, J1
van de Vijver, MJ1
van Tinteren, H1
de Bruin, M1
Hauptmann, M1
Rodenhuis, S1
Linn, SC1
Venkatarajan, S1
LeLeux, TM1
Yang, D1
Rosen, T4
Orengo, I1
Brightman, L1
Warycha, M1
Anolik, R1
Geronemus, R1
Tang, JY1
Marghoob, AA1
Sullivan, TJ1
Firnhaber, JM1
Čeović, R1
Smolković, N1
Pašić, A1
Kostović, K1
Hrsan, D1
Endrizzi, B1
Ahmed, RL1
Ray, T1
Dudek, A1
Lee, P2
Zimmermann, A1
Walt, H1
Haller, U1
Baas, P1
Klein, SD1
Clayton, AS1
Stasko, T1
JOHNSON, RO1
LANGE, RD1
KISKEN, WA1
CURRERI, AR1
CASE, RW2
LAOR, Y2
Schmook, T1
Stockfleth, E1
Beyeler, M1
Morcinek, J1
Burg, G1
McGillis, ST1
Fein, H1
Chetty, R1
Serra, S1
Hsieh, E1
Schmerber, S1
Righini, Ch1
Soriano, E1
Delalande, C1
Dumas, G1
Reyt, E1
Lavieille, JP1
Snipes, CJ1
Sniezek, PJ1
Walling, HW1
Copcu, E1
Sivrioglu, N1
Baytekin, C1
Er, S1
Koc, B1
Hantash, BM1
Stewart, DB1
Cooper, ZA1
Rehmus, WE1
Koch, RJ1
Resnik, KS1
DiLeonardo, M1
Gibbons, G1
Prager, R1
Khachemoune, A1
Gross, K1
Kircik, L1
Kricorian, G1
Koh, DM1
Dzik-Jurasz, A1
O'Neill, B1
Tait, D1
Husband, JE1
Brown, G1
Mitropoulos, P1
Norman, R1
Chiaffitelli, C1
Suarez Halty, L1
Cieplinski, W1
Carter, DM2
Balin, AK1
Rogers, M1
Bean, DJ1
Rees, RS1
O'Leary, JP1
Lynch, JB1
Swanson, NA1
Cesteleyn, L1
Akuamoa-Boateng, E1
Dillaha, CJ1
Jansen, GT1
Honeycutt, WM1
Bradford, AC1
Seniukov, MV1
Goldobenko, GV1
Mardynskiĭ, IuS1
Lushnikov, EF1
Skoropad, IuD1
Hazen, PG1
Taub, SJ1
Albright, SD1
Glickman, FS1
Shelley, WB1
Wood, MG1
Kurtis, B2
Yaffee, HS1
Grots, I1
Monheit, GD1
Kovacs, L1
Casson, P1
Rozenman, Y1
Gurewich, J1
Gotsman, MS1
Goldberg, H1
Tsalik, M1
Bernstein, Z1
Haim, N1
Tsuji, T1
Otake, N1
Nishimura, M1
Gupta, AK1
Turnbull, DH1
Foster, FS1
Harasiewicz, KA1
Shum, DT1
Prussick, R1
Watteel, GN1
Hurst, LN1
Sauder, DN1
Miller, BH2
Shavin, JS1
Cognetta, A1
Taylor, RJ1
Salasche, S1
Korey, A1
Orenberg, EK2
Johnson, MR1
Hageboutros, A1
Wang, K1
High, L1
Smith, JB1
Diasio, RB1
Telfer, NR1
Colver, GB1
Bowers, PW1
Romagosa, R1
Saap, L1
Givens, M1
Salvarrey, A1
He, JL1
Hsia, SL1
Taylor, JR1
Vander Straten, M1
Weitzul, S1
Cockerell, CJ1
Tyring, SK1
Nguyen, TH1
Ho, DQ1
Miki, Y1
Kawatsu, T1
Matsuda, H1
Yamada, T1
Kahata, A1
Reymann, F4
Di Pietro, S1
Milani, A1
Volterrani, F1
Andrews, JM1
Stone, SP1
Kaplan, LA1
Walter, JF1
Macknet, KD1
Starzycki, Z1
Lewis, MB1
Labandter, HP2
Ryan, RF8
Kurka, M1
Orfanos, CE1
Pullmann, H1
Mohs, FE1
Jones, DL1
Bloom, RF1
Gartmann, H2
Scialla, SJ1
Miskoff, RA1
Amon, RB1
Goodkin, PE1
Auerbach, R1
Mansell, PW1
Litwin, MS8
Ichinose, H2
Krementz, ET5
Habal, MB1
Biano, G1
Cavins, JA3
Boileau, GA1
Murray, JE1
Hodge, SJ1
Schrodt, GR1
Owen, LG1
Freeman, RG1
Avant, WH1
Huff, RC1
Golematis, BC1
Delikaris, PG1
Haritopoulos, NK1
Setakis, NG1
Greenway, HT1
Koperski, JA1
Lowe, N1
Brown, DM1
Inui, M1
Korey, AG1
Luck, EE1
Weppelmann, B1
Wheeler, RH1
Peters, GE1
Stephens, S1
Spencer, SA1
Meredith, RF1
Kim, RY1
Salter, MM1
Degner, RA1
Kerley, SW1
McGregor, DH1
Dixon, AY1
Poljacki, M1
Stojanović, S1
Svilar, V1
Sillman, FH1
Sedlis, A1
Boyce, JG1
Denecke, H1
Roloff, R1
Marks, MW1
Kastl, J1
Horácek, J1
Epstein, E1
Leidi, L1
Maina, G1
Rappelli, F1
Cocola, L1
Durando, C1
Donegan, WL1
Harris, HS1
Weidner, F1
Stolte, M1
Remy, W1
Stüttgen, G1
Costanza, ME1
Dayal, Y1
Binder, S1
Nathanson, L1
Snyderman, RK3
Starzynski, TE2
Schnellen, B1
Ehinger, H1
Dogliotti, M1
Sams, WM1
Dickinson, JT1
Rooker, DW1
Leonard, JR1
Watt, J1
Korfsmeier, KH1
Gründer, K1
Leyh, F1
Moskalik, KG1
Kozlov, AP1
Akimov, AA1
Lynch, PJ1
Weber, G1
Meinert, W1
Littlewood, M1
Murray, DS1
Weinstein, GD1
Zala, L1
Lasser, A1
Johnson, A1
Moynahan, EJ1
Peck, GL1
Reed, RR1
Kremetz, ET1
Watt, TL1
Bragg, FE1
Burgess, GH2
Bloch, A1
Stoll, H1
Healy, JB1
Ashton, H1
Beveridge, GW1
Stevenson, CJ1
Zackheim, HS1
Farber, EM1
Reed, RJ4
Pollock, WJ1
Ebner, H3
Gleason, MC1
Lopes, CF1
Armond, S1
Trnka, J2
Yamamoto, K1
Sasaki, S1
Walker, MJ1
Ott, F2
Storck, H1
Avrach, W1
Ziprkowski, L1
Sykes, MP1
Salem, P1
Joffe, B1
Gueguen, MH1
Zeligman, I1
Lutzner, MA1
Scott, CI1
Banzet, P1
De la Caffinière, JY1
Dufourmentel, C1
Schwartz, SH1
Bardos, TJ1
Laugier, P1
Hunziker, N1
Uthida-Tanaka, AM1
Nakamura, S1
de Britto-Costa, R1
de Tavares Mello, E1
Nadel, RS1
Nitze, HR1
Ganzer, U1
Glintzer, W1
Williams, AC1
Landes, E1
Spencer, SK1
Kierland, RR1
Bergonzini, R1
Vaccari, R1
Zagnoli, P1
Scarpa, C1
Garcia-Perez, A1
Aparicio, M1
Carapeto, FJ1
Klostermann, GF2
Achten, G1
Van Oost, A2
Ledoux-Corbusier, M2
De Moragas, JM1
Gimenez-Camarasa, JM1
Midana, A1
Leigheb, G1
Llombart Bosch, M1
Espinosa Cabañero, JA1
Binazzi, M1
Almeida Gonçalves, JC1
De Noronha, T1
Bettley, FR1
Weitgasser, H1
Kastl, WH1
Knoepp, LF1
Soosaar, A1
Anderson, FE1
Johnson, AM1
Havyatt, MT1

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial[NCT00847912]Phase 4954 participants (Actual)Interventional2009-06-26Completed
Calcipotriol Plus 5-Fluorouracil Immunotherapy for Skin Cancer Prevention in Organ Transplant Recipients[NCT04642287]Phase 264 participants (Anticipated)Interventional2026-01-31Not yet recruiting
Calcipotriol Plus 5-Flourouracil Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients[NCT04329221]Phase 262 participants (Anticipated)Interventional2026-01-01Not yet recruiting
Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease: a Multicenter Randomized Controlled Trial[NCT03909646]Phase 4250 participants (Anticipated)Interventional2019-05-27Recruiting
Phase I, Dual Arm, Open-Label, Trial of Intralesional 5-Fluorouracil (5FU) and Intralesional 5FU Combined With Topical Imiquimod in Patients With Squamous Cell Carcinoma (SCC) of the Lower Extremities[NCT03370406]Phase 130 participants (Anticipated)Interventional2018-08-03Recruiting
Research on Current Prototypes of the Digiclamp. Short Term and Long Term Outcomes of Treating Adults With Achrocordons (Skin Tags)[NCT03259295]20 participants (Actual)Interventional2017-12-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Hazard Ratio for Surgically Treated KC

(NCT00847912)
Timeframe: date of randomization to last visit before end of study follow up (6/30/2013), assessed up to four years

Interventionparticipants (Number)
Arm 1: 5-fluorouracil182
Arm 2: Placebo, Vehicle Control177

The Time to Diagnosis of the First Keratinocyte Carcinoma (KC) on the Face or Ears for Which Surgery is Performed

Diagnosis of the first Primary Basil Cell Carcinoma (BCC) or primary Squamous Cell Carcinoma (SCC) on the face or ears that was removed surgically. (NCT00847912)
Timeframe: From randomization to last visit prior to end of study date (6/30/2013), assessed up to four years

Interventionyears (Median)
Arm 1: 5-fluorouracil3.37
Arm 2: Placebo, Vehicle Control3.52

Percentage of Discoloration Among Subjects

Percentage of subjects who develop discoloration at the site of removal (NCT03259295)
Timeframe: 3 months

InterventionParticipants (Count of Participants)
Skin Tag Removal Initial Visit Plus Follow-up3

Percentage of Pain/Numbness Where Skin Tag Was Removed

Percentage of subjects who develop pain/numbness at the site of removal (NCT03259295)
Timeframe: 3 months

InterventionParticipants (Count of Participants)
Skin Tag Removal Initial Visit Plus Follow-up0

Percentage of Permanent Scars Among Lesion Sites

Percentage of subjects who develop a scar at the removal site (NCT03259295)
Timeframe: 3 months

InterventionParticipants (Count of Participants)
Skin Tag Removal Initial Visit Plus Follow-up1

Percentage of Scar Tissue Formation Among Lesion Sites

Percentage of subjects who develop scar tissue or keloid at the site of removal (NCT03259295)
Timeframe: 3 months

InterventionParticipants (Count of Participants)
Skin Tag Removal Initial Visit Plus Follow-up0

Re-occurrence Rate of Skin Tags

Percentage of subjects who experience a re-occurrence of the skin tag at the removal site. (NCT03259295)
Timeframe: 3 months

InterventionParticipants (Count of Participants)
Skin Tag Removal Initial Visit Plus Follow-up0

Reviews

39 reviews available for fluorouracil and Carcinoma, Basal Cell, Pigmented

ArticleYear
Advances in Topical Treatments of Cutaneous Malignancies.
    American journal of clinical dermatology, 2023, Volume: 24, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiqui

2023
Nonsurgical Treatments for Nonmelanoma Skin Cancer.
    Dermatologic clinics, 2019, Volume: 37, Issue:4

    Topics: Administration, Cutaneous; Anilides; Antineoplastic Agents; Antineoplastic Agents, Immunological; Bi

2019
Topical treatments for skin cancer.
    Advanced drug delivery reviews, 2020, 01-01, Volume: 153

    Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; D

2020
Field cancerization: Treatment.
    Journal of the American Academy of Dermatology, 2020, Volume: 83, Issue:3

    Topics: Administration, Cutaneous; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Carcinogenesi

2020
Actinic Keratoses: Reconciling the Biology of Field Cancerization with Treatment Paradigms.
    The Journal of investigative dermatology, 2021, Volume: 141, Issue:4

    Topics: Administration, Cutaneous; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Transformation, Neo

2021
Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
    Journal of drugs in dermatology : JDD, 2021, 02-01, Volume: 20, Issue:2

    Topics: Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Fluorouracil;

2021
Nonsurgical Therapies for Basal Cell Carcinoma: A Review.
    Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:9

    Topics: Administration, Cutaneous; Aminoquinolines; Anilides; Antineoplastic Agents; Biphenyl Compounds; Car

2017
    Annales de dermatologie et de venereologie, 2018, Volume: 145 Suppl 5

    Topics: Alopecia; Anilides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Basal Cel

2018
Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
    Dermatologic clinics, 2019, Volume: 37, Issue:3

    Topics: Administration, Cutaneous; Administration, Oral; Antineoplastic Agents; Carcinoma, Basal Cell; Carci

2019
Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:9

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell;

2013
Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis.
    Photodermatology, photoimmunology & photomedicine, 2015, Volume: 31, Issue:1

    Topics: Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fl

2015
Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors?
    Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:5

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neop

2015
Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.
    International journal of dermatology, 2016, Volume: 55, Issue:3

    Topics: Administration, Oral; Anilides; Antineoplastic Agents; Biphenyl Compounds; Capecitabine; Carcinoma,

2016
Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know.
    The American journal of medicine, 2016, Volume: 129, Issue:7

    Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy;

2016
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders.
    The Journal of dermatological treatment, 2009, Volume: 20, Issue:6

    Topics: Administration, Cutaneous; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic

2009
Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
    Archives of dermatology, 2009, Volume: 145, Issue:12

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, S

2009
Intralesional agents in the management of cutaneous malignancy: a review.
    Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:2

    Topics: Aminolevulinic Acid; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bleomycin; Carci

2011
Treating skin cancer with topical cream.
    Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:9

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac;

2010
Intralesional chemotherapy for nonmelanoma skin cancer: a practical review.
    Journal of the American Academy of Dermatology, 2010, Volume: 63, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamou

2010
Do lasers or topicals really work for nonmelanoma skin cancers?
    Seminars in cutaneous medicine and surgery, 2011, Volume: 30, Issue:1

    Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents;

2011
Emerging treatments and signaling pathway inhibitors.
    Seminars in cutaneous medicine and surgery, 2011, Volume: 30, Issue:4 Suppl

    Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Basal Cell Nevus Syndrome; Benzamides; Carcinoma,

2011
Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens.
    Current opinion in ophthalmology, 2012, Volume: 23, Issue:5

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, S

2012
Diagnosis and treatment of Basal cell and squamous cell carcinoma.
    American family physician, 2012, Jul-15, Volume: 86, Issue:2

    Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cry

2012
Treatment of nonmelanoma skin cancer in organ transplant recipients: review of responses to a survey.
    Journal of the American Academy of Dermatology, 2003, Volume: 49, Issue:3

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cryosurgery; Electrosurg

2003
Current treatment patterns in non-melanoma skin cancer across Europe.
    The Journal of dermatological treatment, 2003, Volume: 14 Suppl 3

    Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryothe

2003
[Cutaneous neoplasms].
    Praxis, 2003, Sep-03, Volume: 92, Issue:36

    Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bio

2003
Topical treatment strategies for non-melanoma skin cancer and precursor lesions.
    Seminars in cutaneous medicine and surgery, 2004, Volume: 23, Issue:3

    Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Ag

2004
Nevoid basal cell carcinoma syndrome (Gorlin syndrome): updated review of minimally invasive treatments.
    Cutis, 2008, Volume: 81, Issue:1

    Topics: Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Cryosurger

2008
Dermatological aspects of aging.
    The Medical clinics of North America, 1983, Volume: 67, Issue:2

    Topics: Adult; Aged; Aging; Animals; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatitis; Female; Fl

1983
Treatment of skin cancer using multiple modalities.
    Journal of the American Academy of Dermatology, 1982, Volume: 7, Issue:2

    Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Electrosurgery; Female; F

1982
Advances in the treatment of basal cell carcinoma: the promise of pharmacologic therapy.
    Advances in dermatology, 2000, Volume: 16

    Topics: Adjuvants, Immunologic; Carcinoma, Basal Cell; Fluorouracil; Humans; Interferons; Photochemotherapy;

2000
Nonmelanoma skin cancer.
    Current treatment options in oncology, 2002, Volume: 3, Issue:3

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diet Therapy; Fluorouracil; Humans; Life Style; Neo

2002
A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil.
    Obstetrical & gynecological survey, 1985, Volume: 40, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Anal Canal; Anus Neoplasms; Carc

1985
The use of cytotoxic drugs in the surgery of malignant disease.
    The Journal of bone and joint surgery. British volume, 1968, Volume: 50, Issue:3

    Topics: Abdominal Neoplasms; Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Carcinoma,

1968
[Use of optical quantum generators (lasers) in oncology].
    Voprosy onkologii, 1972, Volume: 18, Issue:8

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Basal Cell; Carcinom

1972
The action of antimetabolites in the skin: methotrexate for psoriasis.
    Advances in biology of skin, 1972, Volume: 12

    Topics: Carcinoma, Basal Cell; Cell Division; DNA; Fluorouracil; Humans; Injections, Intradermal; Keratosis;

1972
Local cytostatic chemotherapy and immunotherapy.
    Geriatrics, 1968, Volume: 23, Issue:5

    Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Drug Hypersensitivity; Fluorouracil; Humans; Neoplasms

1968
Topical treatment of skin tumours with 5-fluorouracil.
    The British journal of dermatology, 1970, Volume: 82, Issue:2

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratosis; Skin Neoplasms

1970
Topical antimetabolites.
    Annual review of medicine, 1970, Volume: 21

    Topics: Antimetabolites; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Folic Acid Antagonists;

1970

Trials

24 trials available for fluorouracil and Carcinoma, Basal Cell, Pigmented

ArticleYear
Rate and Proportion of Malignant Skin Biopsies for Basal Cell and Squamous Cell Carcinoma on the Face and Ears After a Single Course of Topical 5-Fluorouracil: The Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2021, 04-01, Volume: 47, Issue:4

    Topics: Administration, Topical; Aged; Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Basal Cell; Carci

2021
Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment.
    The British journal of dermatology, 2018, Volume: 178, Issue:1

    Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Choice Behavior; Dermatologic Agents; Drug Therapy, Comb

2018
Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
    JAMA dermatology, 2018, 02-01, Volume: 154, Issue:2

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Squamou

2018
Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
    Journal of the American Academy of Dermatology, 2018, Volume: 79, Issue:3

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Basa

2018
Comparison of long-term cosmetic outcomes for different treatments of superficial basal cell carcinoma.
    Journal of the American Academy of Dermatology, 2018, Volume: 79, Issue:5

    Topics: Adult; Aged; Carcinoma, Basal Cell; Dermatologic Surgical Procedures; Esthetics; Female; Fluorouraci

2018
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
    JCI insight, 2019, 03-21, Volume: 4, Issue:6

    Topics: Adaptive Immunity; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Calcitri

2019
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
    JCI insight, 2019, 03-21, Volume: 4, Issue:6

    Topics: Adaptive Immunity; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Calcitri

2019
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
    JCI insight, 2019, 03-21, Volume: 4, Issue:6

    Topics: Adaptive Immunity; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Calcitri

2019
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
    JCI insight, 2019, 03-21, Volume: 4, Issue:6

    Topics: Adaptive Immunity; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Calcitri

2019
Characteristics of Keratinocyte Carcinomas and Patients with Keratinocyte Carcinomas Following a Single 2-4 Week Course of Topical 5-fluorouracil on the Face and Ears.
    Acta dermato-venereologica, 2019, Jun-01, Volume: 99, Issue:7

    Topics: Administration, Topical; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; D

2019
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    The Lancet. Oncology, 2013, Volume: 14, Issue:7

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antim

2013
Fluorouracil and other predictors of morpheaform basal cell carcinoma among high-risk patients: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    JAMA dermatology, 2014, Volume: 150, Issue:3

    Topics: Administration, Topical; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic

2014
Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
    The British journal of dermatology, 2014, Volume: 171, Issue:6

    Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherap

2014
Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial.
    The Journal of investigative dermatology, 2016, Volume: 136, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cel

2016
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Breast Neoplasms; Carboplatin;

2011
Facial resurfacing for nonmelanoma skin cancer prophylaxis.
    Archives of dermatology, 2006, Volume: 142, Issue:8

    Topics: Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Disease-Fr

2006
Selective cytotoxic effect of topical 5-fluorouracil.
    Archives of dermatology, 1983, Volume: 119, Issue:9

    Topics: Administration, Topical; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind

1983
Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel.
    Journal of the American Academy of Dermatology, 1997, Volume: 36, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Basal Cell; Clin

1997
A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2000, Volume: 26, Issue:4

    Topics: Administration, Topical; Carcinoma, Basal Cell; Double-Blind Method; Drug Carriers; Fluorouracil; Hu

2000
The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma.
    Journal of the American Academy of Dermatology, 1992, Volume: 27, Issue:5 Pt 1

    Topics: Adult; Aged; Carcinoma, Basal Cell; Double-Blind Method; Drug Carriers; Drug Implants; Female; Fluor

1992
A phase I study of prolonged infusion 5-fluorouracil and concomitant radiation therapy in patients with squamous cell cancer of the head and neck.
    International journal of radiation oncology, biology, physics, 1991, Volume: 20, Issue:2

    Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Admini

1991
A clinical trial of the use of 5-fluouracil in the treatment of some cutaneous malignancies.
    British journal of plastic surgery, 1973, Volume: 26, Issue:2

    Topics: Adult; Aged; Carcinoma, Basal Cell; Clinical Trials as Topic; Facial Neoplasms; Female; Fluorouracil

1973
The use of topical 5-fluorouracil in the treatment of skin tumours--preliminary report.
    Journal of the Irish Medical Association, 1969, Volume: 62, Issue:380

    Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Clinical Trials as Topic; Female; Fluorouracil; Humans; Kera

1969
Treatment of basal cell carcinoma with 5-fluorouracil (5-FU) ointment.
    Dermatologica, 1970, Volume: 140

    Topics: Aged; Carcinoma, Basal Cell; Clinical Trials as Topic; Female; Fluorouracil; Humans; Male; Middle Ag

1970
Treatment of skin epitheliomas with 5-fluorouracil (5-FU) ointment. Influence of therapeutic design on recurrence of lesions.
    Dermatologica, 1970, Volume: 140

    Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinoma, Squamous Cell; Clinical Trials as T

1970
[Therapeutic trial with 5-fluorouracil ointment].
    Hospital (Rio de Janeiro, Brazil), 1970, Volume: 77, Issue:4

    Topics: Adult; Aged; Carcinoma, Basal Cell; Clinical Trials as Topic; Evaluation Studies as Topic; Facial Ne

1970
Tumors of the skin. V. Local administration of anti-tumor agents to multiple superficial basal cell carcinomas.
    The Journal of investigative dermatology, 1965, Volume: 45, Issue:6

    Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Fluorouracil; Humans; Neopla

1965

Other Studies

187 other studies available for fluorouracil and Carcinoma, Basal Cell, Pigmented

ArticleYear
Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis.
    Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:2

    Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorou

2022
Efficacy and safety of laser-assisted combination chemotherapy: A follow-up study of treatment with 5-fluorouracil and cisplatin for basal cell carcinoma.
    Lasers in surgery and medicine, 2022, Volume: 54, Issue:1

    Topics: Carcinoma, Basal Cell; Cisplatin; Fluorouracil; Follow-Up Studies; Humans; Lasers; Photochemotherapy

2022
In vitro 5-Fluorouracil resistance produces enhanced photodynamic therapy damage in SCC and tumor resistance in BCC.
    Journal of photochemistry and photobiology. B, Biology, 2022, Volume: 233

    Topics: Aminolevulinic Acid; Animals; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans;

2022
RF - Intralesional 5-Fluorouracil in the Treatment of Nonmelanoma Skin Cancer.
    Actas dermo-sifiliograficas, 2023, Volume: 114, Issue:3

    Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Injections, Intralesional; Keratoacanthoma; Skin Neopla

2023
Comprehensive treatment of basal cell carcinoma in nevoid basal cell carcinoma syndrome with 5-fluorouracil and salicylic acid.
    Dermatologic therapy, 2022, Volume: 35, Issue:12

    Topics: Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Fluorouracil; Humans; Salicylic Acid; Skin Neoplas

2022
[Current Management of Basal Cell Carcinoma].
    Deutsche medizinische Wochenschrift (1946), 2023, Volume: 148, Issue:17

    Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Cryotherapy; Fluorouracil; Humans; Imiquimod

2023
Cryosurgery and 5-Fluorouracil Combination Therapy for Treatment of Bowen's Disease and Superficial Basal Cell Carcinoma.
    Journal of drugs in dermatology : JDD, 2023, Dec-01, Volume: 22, Issue:12

    Topics: Bowen's Disease; Carcinoma, Basal Cell; Cryosurgery; Fluorouracil; Humans; Retrospective Studies; Sk

2023
Topical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery.
    Journal of drugs in dermatology : JDD, 2020, May-01, Volume: 19, Issue:5

    Topics: Administration, Cutaneous; Aged; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Female; Fluorouracil

2020
Efficacy and Safety of Laser-Assisted Combination Chemotherapy: An Explorative Imaging-Guided Treatment With 5-Fluorouracil and Cisplatin for Basal Cell Carcinoma.
    Lasers in surgery and medicine, 2021, Volume: 53, Issue:1

    Topics: Carcinoma, Basal Cell; Cisplatin; Fluorouracil; Humans; Lasers, Gas; Proof of Concept Study; Skin Ne

2021
Optimizing the effective doses of mitomycin C, 5-fluorouracil, and their combination on cultivated basal cell carcinoma.
    Arquivos brasileiros de oftalmologia, 2021, Volume: 84, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Female; Fluorouracil; H

2021
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
    Journal of drugs in dermatology : JDD, 2021, 03-01, Volume: 20, Issue:3

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols;

2021
Long-term efficacy and safety of imiquimod 5% and fluorouracil 1% creams in medical monotherapy of complex eyelid basal cell carcinomas.
    European journal of ophthalmology, 2022, Volume: 32, Issue:4

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid

2022
Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer.
    International journal of cancer, 2017, 09-15, Volume: 141, Issue:6

    Topics: Animals; Antineoplastic Agents; Carboplatin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cetuxi

2017
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
    The Journal of investigative dermatology, 2018, Volume: 138, Issue:3

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cel

2018
Comparing Topical Treatments for Basal Cell Carcinoma.
    The Journal of investigative dermatology, 2018, Volume: 138, Issue:3

    Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neopla

2018
Cells to Surgery Quiz: July 2018.
    The Journal of investigative dermatology, 2018, Volume: 138, Issue:7

    Topics: Administration, Cutaneous; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Diseas

2018
Characterization of stem-like cancer cells in basal cell carcinoma and its surgical margins.
    Experimental dermatology, 2018, Volume: 27, Issue:10

    Topics: 5'-Nucleotidase; Antineoplastic Agents; Biomarkers; Carcinoma, Basal Cell; Cell Survival; Cisplatin;

2018
Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
    Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4

    Topics: Administration, Cutaneous; Aged; California; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Compar

2019
Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study.
    Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4

    Topics: Aged; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal

2019
Effects of new keratinocyte carcinomas on skin-related quality of life: Results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial.
    Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:5

    Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; C

2019
Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solution.
    Dermatologic therapy, 2019, Volume: 32, Issue:3

    Topics: Adult; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Salicylic Acid; Skin

2019
Topical chemotherapy for numerous superficial basal cell carcinomas years after isolated limb perfusion for melanoma.
    Cutis, 2019, Volume: 103, Issue:5

    Topics: Administration, Cutaneous; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents

2019
Treating basal-cell carcinoma in a real life setting.
    The Lancet. Oncology, 2013, Volume: 14, Issue:7

    Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod

2013
Effect of pigmentation on photodynamic therapy.
    The Lancet. Oncology, 2013, Volume: 14, Issue:9

    Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Pho

2013
Effect of pigmentation on photodynamic therapy - Authors' reply.
    The Lancet. Oncology, 2013, Volume: 14, Issue:9

    Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Pho

2013
Treatment of cancer in a child with ocular xeroderma pigmentosa (XP) in Malawi.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:8

    Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool;

2014
Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2014, Volume: 40, Issue:7

    Topics: Acitretin; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Basal Cell; Carcinoma, Sq

2014
Resident rounds part III: plaque on left areola of an African-American woman.
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:6

    Topics: Administration, Topical; Aged; Antimetabolites, Antineoplastic; Biopsy; Black or African American; B

2014
Usage and patient experience of 5% fluorouracil cream.
    Clinical and experimental dermatology, 2015, Volume: 40, Issue:1

    Topics: Antimetabolites, Antineoplastic; Bowen's Disease; Carcinoma, Basal Cell; Cost Control; Fluorouracil;

2015
Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
    Current problems in dermatology, 2015, Volume: 46

    Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Ag

2015
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal.
    The British journal of dermatology, 2015, Volume: 172, Issue:1

    Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Pho

2015
Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'.
    The British journal of dermatology, 2015, Volume: 172, Issue:1

    Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Pho

2015
Commentary on 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial'.
    The British journal of dermatology, 2015, Volume: 172, Issue:1

    Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Pho

2015
Tumors of the skin. VI. Study on effects of local administration of 5-fluorouracil in basal cell carcinoma.
    The Journal of investigative dermatology, 1966, Volume: 47, Issue:1

    Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Fol

1966
Fast-growing cutaneous squamous cell carcinoma in a patient treated with vismodegib.
    Dermatology (Basel, Switzerland), 2015, Volume: 230, Issue:2

    Topics: Aged, 80 and over; Anilides; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basa

2015
Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil.
    Journal of the American Academy of Dermatology, 2015, Volume: 72, Issue:3

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma,

2015
Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation.
    Cutis, 2015, Volume: 95, Issue:2

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil

2015
Integrative approach in prevention and therapy of basal cellular carcinoma by association of three actives loaded into lipid nanocarriers.
    Journal of photochemistry and photobiology. B, Biology, 2015, Volume: 147

    Topics: Amaranthus; Antioxidants; Calorimetry, Differential Scanning; Carcinoma, Basal Cell; Drug Carriers;

2015
Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
    Journal of the American Academy of Dermatology, 2015, Volume: 73, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcino

2015
Weekly Multi-agent Chemotherapy (CMF-b) for Advanced Non-melanoma Skin Cancer.
    Anticancer research, 2016, Volume: 36, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marr

2016
Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2016, Volume: 42, Issue:9

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinom

2016
Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: A novel chemotherapeutic approach.
    Orbit (Amsterdam, Netherlands), 2016, Volume: 35, Issue:6

    Topics: Administration, Topical; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Face; Fluorouracil;

2016
Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments.
    Journal of drugs in dermatology : JDD, 2010, Volume: 9, Issue:7

    Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Carcinoma, Squamous

2010
Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer.
    Dermatology (Basel, Switzerland), 2010, Volume: 221, Issue:4

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Basement Membrane; Blister; Carcinoma, Basal Cell; Cry

2010
[Surgical vs nonsurgical treatment of basal cell carcinoma].
    Actas dermo-sifiliograficas, 2010, Volume: 101, Issue:8

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Combined Mo

2010
[Four resected cases with basaloid carcinoma of esophagus--comparison of 5-FU-related enzymes (thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), orotate phosphoribosyl transferase (OPRT)) between basaloid carcinoma and squamous cell carcin
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:11

    Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dihydrouraci

2010
Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil.
    Dermatology online journal, 2010, Dec-15, Volume: 16, Issue:12

    Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antimetabolites; Carcinoma, Basal Cel

2010
Aesthetic evaluation after non-invasive treatment for superficial basal cell carcinoma.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Volume: 27, Issue:5

    Topics: Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Esthetics; Female; Fluorouracil; Humans; Imiqui

2013
Multiple basal cell carcinomas of lower legs with stasis dermatitis: a therapeutic challenge.
    Acta dermatovenerologica Croatica : ADC, 2012, Volume: 20, Issue:3

    Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Hamartoma S

2012
Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, B

2013
Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient.
    Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:2

    Topics: Apoptosis; Breast Neoplasms; Carcinoma, Basal Cell; Floxuridine; Fluorouracil; Humans; Male; Mesopor

2003
INFUSION OF 5-FLUOROURACIL IN CYLINDROMA TREATMENT.
    Archives of otolaryngology (Chicago, Ill. : 1960), 1964, Volume: 79

    Topics: Carcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Basal Cell; Fluorouracil; Humans; Injections, Intra

1964
TUMORS OF THE SKIN. IV. DOUBLE-BLIND STUDY ON EFFECTS OF LOCAL ADMINISTRATION OF ANTI-TUMOR AGENTS IN BASAL CELL CARCINOMA.
    The Journal of investigative dermatology, 1965, Volume: 44

    Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Dactinomycin; Double-Blind Method; Drug Therapy; Fluor

1965
Basaloid squamous carcinoma of the anal canal with an adenoid cystic pattern: histologic and immunohistochemical reappraisal of an unusual variant.
    The American journal of surgical pathology, 2005, Volume: 29, Issue:12

    Topics: Anal Canal; Antibiotics, Antineoplastic; Antigens, CD20; Antimetabolites, Antineoplastic; Antineopla

2005
[The outcome of treatments for carcinoma of the external auditory canal].
    Revue de laryngologie - otologie - rhinologie, 2005, Volume: 126, Issue:3

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemoth

2005
Basal cell carcinoma responding to systemic 5-fluorouracil.
    Journal of the American Academy of Dermatology, 2006, Volume: 54, Issue:6

    Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Humans; Male; Middle Aged; Ski

2006
How can we decide on orbital exenteration for second eye in a patient with basal cell carcinoma?
    Plastic and reconstructive surgery, 2006, Volume: 117, Issue:7

    Topics: Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Cheek; Dose Fractionation, Radiation; Fluorourac

2006
Clinically occult cutaneous metastases.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6

    Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormon

2006
Basal cell carcinoma.
    Dermatology nursing, 2006, Volume: 18, Issue:6

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Causality; Cryosurgery;

2006
5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:4

    Topics: Administration, Topical; Adult; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil

2007
Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation.
    The British journal of radiology, 2008, Volume: 81, Issue:962

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Anus N

2008
[Experience on topical 5-fluoruracil- (5-FU) in cutaneous carcinomatosis. I. Test on the efficiency of topical 5-FU].
    Anales de la Facultad de Medicina, Universidad de la Republica, Montevideo, Uruguay, 1966, Volume: 51, Issue:1

    Topics: Carcinoma, Basal Cell; Cheilitis; Facial Dermatoses; Female; Fluorouracil; Hand Dermatoses; Humans;

1966
Chemical treatment of skin cancer.
    British medical journal, 1967, Jul-15, Volume: 3, Issue:5558

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Colchicine; Fluorouracil; Humans; Methotrexate; Pod

1967
Combination chemotherapy for the treatment of metastatic basal cell carcinoma of the scrotum. A case report.
    Clinical oncology, 1984, Volume: 10, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Cisplatin; Fluorou

1984
Management of common skin tumours.
    The Medical journal of Australia, 1980, Sep-06, Volume: 2, Issue:5

    Topics: Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Dermatitis, Seborrhei

1980
Carcinoma of the hand: a 20-year experience.
    Southern medical journal, 1984, Volume: 77, Issue:8

    Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Female; Fluorouracil; Fol

1984
Basal cell carcinoma. Treatment modalities and recommendations.
    Primary care, 1983, Volume: 10, Issue:3

    Topics: Carcinoma, Basal Cell; Cryosurgery; Electrosurgery; Facial Neoplasms; Fluorouracil; Humans; Neoplasm

1983
[Maxillofacial surgical treatment of basaliomas in the basocellular nevus syndrome].
    Acta stomatologica Belgica, 1983, Volume: 80, Issue:1

    Topics: Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Facial Neoplasms; Female; Fluorouracil; Humans; Ma

1983
[Procedure and results of combined radiation and surgical treatment of laryngeal cancer patients].
    Meditsinskaia radiologiia, 1983, Volume: 28, Issue:9

    Topics: Adult; Aged; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality T

1983
Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene.
    Dermatologica, 1984, Volume: 168, Issue:6

    Topics: Administration, Topical; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Child; Dinitrochlorobenze

1984
Porokeratosis associated with basal cell carcinoma.
    Cutis, 1982, Volume: 29, Issue:5

    Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratosis; Skin Neoplasms

1982
Nodular superficial pigmented basal cell epitheliomas.
    Archives of dermatology, 1982, Volume: 118, Issue:11

    Topics: Administration, Topical; Carcinoma, Basal Cell; Fluorouracil; Humans; Male; Middle Aged; Neoplasms,

1982
Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU).
    The Journal of dermatologic surgery and oncology, 1980, Volume: 6, Issue:2

    Topics: Adult; Carcinoma, Basal Cell; Fluorouracil; Humans; Injections, Intradermal; Keratoacanthoma; Male;

1980
"Ecdysis" secondary to 5-fluorouracil.
    Cutis, 1980, Volume: 25, Issue:6

    Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Middle Aged; Skin; Skin Neoplasms; Steven

1980
Facial blemishes and their treatment.
    Otolaryngologic clinics of North America, 1980, Volume: 13, Issue:2

    Topics: Carcinoma, Basal Cell; Chemexfoliation; Cryosurgery; Curettage; Electrosurgery; Facial Dermatoses; F

1980
[Efudix therapy of extensive basal cell carcinomas].
    Zeitschrift fur Hautkrankheiten, 1980, Jun-15, Volume: 55, Issue:12

    Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Ointments; Skin Neopla

1980
Basal cell carcinoma.
    Clinics in plastic surgery, 1980, Volume: 7, Issue:3

    Topics: Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Cryosurgery; Female; Fluorouracil; Humans; Male; N

1980
Myocardial ischemia induced by topical use of 5-fluorouracil.
    International journal of cardiology, 1995, Volume: 49, Issue:3

    Topics: Administration, Topical; Aged; Aged, 80 and over; Angina Pectoris; Carcinoma, Basal Cell; Drug Thera

1995
[Cisplatin-based chemotherapy for advanced basal and squamous cell carcinomas].
    Harefuah, 1994, Volume: 127, Issue:7-8

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Carc

1994
Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome.
    The Journal of dermatology, 1993, Volume: 20, Issue:8

    Topics: Administration, Topical; Back; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Combined Modality T

1993
High frequency 40-MHz ultrasound. A possible noninvasive method for the assessment of the boundary of basal cell carcinomas.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 1996, Volume: 22, Issue:2

    Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Basal Cell; Female; Flu

1996
Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:8

    Topics: Aged; Antimetabolites, Antineoplastic; Blotting, Western; Carcinoma, Basal Cell; Diarrhea; Dihydrour

1999
Guidelines for the management of basal cell carcinoma. British Association of Dermatologists.
    The British journal of dermatology, 1999, Volume: 141, Issue:3

    Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Humans; Interferon Type I; Pal

1999
[Topical chemotherapy for carcinoma of the skin (author's transl)].
    The Japanese journal of antibiotics, 1975, Volume: 28, Issue:1

    Topics: Administration, Topical; Adolescent; Aged; Bleomycin; Bowen's Disease; Carcinoma, Basal Cell; Carcin

1975
Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study.
    Dermatologica, 1979, Volume: 158, Issue:5

    Topics: Administration, Topical; Carcinoma, Basal Cell; Curettage; Fluorouracil; Follow-Up Studies; Humans;

1979
Basal-cell tumors of the lumbar skin after radiotherapy for arthrosis.
    Tumori, 1979, Feb-28, Volume: 65, Issue:1

    Topics: Administration, Topical; Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Joint Diseases;

1979
Squamous-cell carcinoma arising in a basal-cell epithelioma treated with 5-fluorouracil.
    The Journal of dermatologic surgery and oncology, 1979, Volume: 5, Issue:5

    Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Male; Neoplasms, Multi

1979
Extensive malignancies of facial skin treated by perfusion with 5-fluorouracil and conservative excision.
    British journal of plastic surgery, 1979, Volume: 32, Issue:3

    Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Fluorouracil; Human

1979
Basal cell nevus syndrome and adenocarcinoma of the colon. Response to systemic fluorouracil.
    International journal of dermatology, 1979, Volume: 18, Issue:5

    Topics: Adenocarcinoma; Adult; Carcinoma, Basal Cell; Colonic Neoplasms; Female; Fluorouracil; Humans; Nevus

1979
Hypertrophic scarring as a complication of fluorouracil therapy.
    Archives of dermatology, 1979, Volume: 115, Issue:12

    Topics: Adult; Carcinoma, Basal Cell; Cicatrix; Fluocinonide; Fluorouracil; Humans; Hypertrophy; Male; Skin

1979
[Involution of tumor tissue during local treatment of basal cell epithelioma with 5-fluorouracil].
    Folia medica Cracoviensia, 1977, Volume: 19, Issue:2

    Topics: Adult; Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged

1977
A short survey on the use and efficacy of 5-fluorouracil in Australia.
    The Journal of dermatologic surgery and oncology, 1978, Volume: 4, Issue:3

    Topics: Aged; Australia; Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Skin Diseases; Skin Neoplas

1978
5-fluorouracil in management of Gorlin's syndrome.
    The New England journal of medicine, 1978, Apr-20, Volume: 298, Issue:16

    Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Skin Neoplasms; Syndrome

1978
5-fluorouracil in Gorlin's syndrome.
    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1978, Volume: 130, Issue:4

    Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Jaw Diseases; Skin Neoplasms; Syndrome

1978
[Vitamin A acid for the topical management of epithelial neoplasms. Combination with 5-fluorouracil].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1978, Volume: 29, Issue:6

    Topics: Aged; Carcinoma, Basal Cell; Drug Therapy, Combination; Female; Fluorouracil; Humans; Keratosis; Leu

1978
Tendency of fluorouracil to conceal deep foci of invasive basal cell carcinoma.
    Archives of dermatology, 1978, Volume: 114, Issue:7

    Topics: Administration, Topical; Carcinoma, Basal Cell; Face; Fluorouracil; Humans; Neoplasm Recurrence, Loc

1978
[Topical use of antineoplastic agents in precancerous conditions of the skin].
    Zeitschrift fur Hautkrankheiten, 1977, Apr-15, Volume: 52, Issue:8

    Topics: Administration, Topical; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Kera

1977
Basal-cell carcinoma. A case unmasked by systemic fluorouracil therapy.
    JAMA, 1976, May-31, Volume: 235, Issue:22

    Topics: Administration, Topical; Carcinoma, Basal Cell; Diarrhea; Fluorouracil; Humans; Injections, Intraven

1976
Topical 5-fluorouracil and the basal-cell-nevus syndrome.
    The New England journal of medicine, 1976, Sep-16, Volume: 295, Issue:12

    Topics: Administration, Topical; Carcinoma, Basal Cell; Fluorouracil; Humans; Nevus

1976
Letter: Basal cell carcinoma.
    New York state journal of medicine, 1975, Volume: 75, Issue:13

    Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Methods

1975
Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers.
    Cancer research, 1975, Volume: 35, Issue:5

    Topics: Administration, Topical; Biopsy; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquamous;

1975
The "turban" nevoid basal cell syndrome. Current management with surgery, chemotherapy and immunotherapy.
    International surgery, 1975, Volume: 60, Issue:9

    Topics: Adult; Bone Cysts; Carcinoma, Basal Cell; Dinitrochlorobenzene; Fluorouracil; Humans; Jaw Diseases;

1975
Topical 5-fluorouracil treatment of superficial basal cell epithelioma. A light and electron microscopic study.
    Journal of cutaneous pathology, 1975, Volume: 2, Issue:6

    Topics: Administration, Topical; Adult; Carcinoma, Basal Cell; Cell Nucleus; Cytoplasm; Endoplasmic Reticulu

1975
Intradermal 5-fluorouracil in the treatment of basal cell carcinoma of the face.
    Southern medical journal, 1976, Volume: 69, Issue:5

    Topics: Aged; Carcinoma, Basal Cell; Facial Neoplasms; Female; Fluorouracil; Humans; Injections, Intradermal

1976
Current thoughts on the surgical treatment of rectal cancer.
    The American journal of gastroenterology, 1976, Volume: 65, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil;

1976
Metastatic basal cell carcinoma: report of a case presenting with respiratory failure.
    The American journal of the medical sciences, 1991, Volume: 301, Issue:6

    Topics: Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neopla

1991
[The importance of local administration of 5% 5-fluorouracil in the therapy of senile keratoses and basocellular carcinoma].
    Medicinski pregled, 1989, Volume: 42, Issue:3-4

    Topics: Administration, Topical; Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratosis; Male;

1989
Preoperative radio-chemotherapy in anal carcinoma.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1988, Volume: 110

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Basal Cell; Carcino

1988
Topical 5-fluorouracil in treatment of carcinoma of nasal floor and nasal alae.
    Annals of plastic surgery, 1988, Volume: 20, Issue:1

    Topics: Administration, Topical; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Th

1988
[Multiple basalomas following long-term intake of arsenic].
    Dermatologische Monatschrift, 1985, Volume: 171, Issue:3

    Topics: Administration, Oral; Administration, Topical; Anemia; Arsenic; Arsenites; Carcinoma, Basal Cell; Fe

1985
Fluorouracil paste treatment of thin basal cell carcinomas.
    Archives of dermatology, 1985, Volume: 121, Issue:2

    Topics: Adult; Aged; Carcinoma, Basal Cell; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Lo

1985
[Neoplasms of the vulva].
    Minerva ginecologica, 1985, Volume: 37, Issue:12

    Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Erythroplasi

1985
Factors influencing the success of arterial infusion chemotherapy for cancer of the head and neck.
    American journal of surgery, 1972, Volume: 123, Issue:5

    Topics: Age Factors; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell

1972
[Multicentric metatypical scalp basalioma (ulcus terebans) with perforation into the cranium].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1974, Volume: 25, Issue:2

    Topics: Aged; Autopsy; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Palliative Care; Scalp; Skin Neo

1974
[Comparative topic treatments of basal cell carcinomas and senile keratoses with 5-FU, retinoic acid and DNCB sensitization (author's transl)].
    Dermatologica, 1974, Volume: 148, Issue:2

    Topics: Administration, Topical; Carcinoma, Basal Cell; Chlorobenzenes; Fluorouracil; Humans; Immunotherapy;

1974
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy.
    Cancer, 1974, Volume: 34, Issue:1

    Topics: Aged; Antineoplastic Agents; Biopsy, Needle; Bleomycin; Carcinoma, Basal Cell; Cyclophosphamide; Dru

1974
Treatment of skin cancers and keratoses with 5-fluorouracil.
    Acta chirurgiae plasticae, 1968, Volume: 10, Issue:3

    Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Male; Ointments; Skin Neoplasms

1968
[Therapeutic possibilities in multiple epitheliomas of the trunk skin].
    Zeitschrift fur Haut- und Geschlechtskrankheiten, 1973, Apr-15, Volume: 48, Issue:8

    Topics: Arsenic; Carcinoma, Basal Cell; Electrocoagulation; Female; Fluorouracil; Humans; Long-Term Care; Ma

1973
Actinic keratoses in Bantu albinos. Clinical experiences with the topical use of 5-fluoro-uracil.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1973, Nov-17, Volume: 47, Issue:45

    Topics: Adult; Albinism; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Catechol Oxidase; Child; Female; F

1973
Untoward response with topical fluorouracil.
    Archives of dermatology, 1968, Volume: 97, Issue:1

    Topics: Aged; Carcinoma, Basal Cell; Drug Eruptions; Female; Fluorouracil; Humans; Keratosis; Male; Middle A

1968
Minor surgery for benign and malignant facial lesions.
    American family physician, 1974, Volume: 10, Issue:5

    Topics: Acne Vulgaris; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cicatrix; Cortisone; Curettage; Cyst

1974
[Effect of 5-fluorouracil on protein metabolism of tumors and normal tissues in culture].
    Zeitschrift fur Krebsforschung, 1970, Volume: 74, Issue:1

    Topics: Adenocarcinoma; Animals; Autoradiography; Carcinoma, Basal Cell; Cell Line; Cell Transformation, Neo

1970
[Local treatment of skin neoplasms with 5 per cent fluorouracil ointment (report of 6 cases)].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1972, Volume: 23, Issue:5

    Topics: Adenocarcinoma, Scirrhous; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorourac

1972
Tumors of the skin. Premalignment and malignant.
    Minnesota medicine, 1974, Volume: 57, Issue:10

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorouracil; Humans; Kera

1974
Topical chemotherapy of basal and squamous skin cancers with 5-fluorouracil cream.
    Panminerva medica, 1974, Volume: 16, Issue:3

    Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinom

1974
Combined cytostatic and surgical treatment of extensive basal cell epitheliomata.
    The British journal of dermatology, 1972, Volume: 86, Issue:4

    Topics: Aged; Carcinoma, Basal Cell; Facial Neoplasms; Fluorouracil; Humans; Male; Middle Aged; Skin Transpl

1972
[Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
    Dermatologica, 1972, Volume: 145, Issue:5

    Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Melanoma; Middl

1972
Local chemotherapy in cutaneous neoplasms.
    JAMA, 1972, Nov-27, Volume: 222, Issue:9

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Skin Neoplasms

1972
Multiple basal cell epitheliomas with sebaceous differentiation.
    Archives of dermatology, 1973, Volume: 107, Issue:1

    Topics: Carcinoma, Basal Cell; Cell Differentiation; Child; Curettage; Diagnosis, Differential; Electrosurge

1973
The clinical application of 5-fluorouracil in the treatment of skin lesions. Comment.
    Plastic and reconstructive surgery, 1973, Volume: 52, Issue:3

    Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Skin Neoplasms

1973
Topical use of 5-fluorouracil.
    The Medical journal of Australia, 1973, Jun-09, Volume: 1, Issue:23

    Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Neoplasm Recurrence, Local; Skin Neoplasm

1973
Multiple basal cell naevus syndrome--successful treatment of basal cell tumours with 5-fluorouracil.
    Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:7

    Topics: Adult; Carcinoma, Basal Cell; Dentigerous Cyst; Fluorouracil; Humans; Jaw Diseases; Male; Skin Neopl

1973
Hypertrophic scar after cryotherapy and topical tretinoin.
    Archives of dermatology, 1973, Volume: 108, Issue:6

    Topics: Administration, Topical; Carcinoma, Basal Cell; Carmustine; Cicatrix; Connective Tissue; Cryosurgery

1973
Proceedings: Use of 5 fluorouracil in the topical therapy of skin cancer: a review of 157 patients.
    Proceedings. National Cancer Conference, 1972, Volume: 7

    Topics: Administration, Topical; Adult; Aged; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Basosquam

1972
Proceedings: Chemotherapy and immunotherapy for cancer involving the skin.
    Proceedings. National Cancer Conference, 1972, Volume: 7

    Topics: Administration, Topical; Antigens, Bacterial; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinom

1972
Additional observations on the nevoid basal cell epithelioma syndrome. A case report.
    The Journal of the Maine Medical Association, 1973, Volume: 64, Issue:12

    Topics: Adolescent; Carcinoma, Basal Cell; Cysts; Fluorouracil; Humans; Jaw Abnormalities; Jaw Diseases; Jaw

1973
Effect of topical tubercidin on basal cell carcinomas and actinic keratoses.
    Cancer, 1974, Volume: 34, Issue:2

    Topics: Adenosine; Administration, Topical; Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Kerat

1974
The clinical application of 5-fluorouracil in the treatment of skin lesions.
    Plastic and reconstructive surgery, 1968, Volume: 41, Issue:6

    Topics: Adolescent; Adult; Carcinoma, Basal Cell; Child; Child, Preschool; Dermatologic Agents; Fluorouracil

1968
The use of 5-fluorouracil cream to define suitable donor areas.
    Plastic and reconstructive surgery, 1970, Volume: 46, Issue:5

    Topics: Adult; Aged; Carcinoma, Basal Cell; Fluorouracil; Humans; Male; Middle Aged; Ointments; Skin Neoplas

1970
Xeroderma pigmentosum--five-year arrest after total resurfacing of the face.
    Plastic and reconstructive surgery, 1970, Volume: 46, Issue:6

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; Dermabrasion; Electrosurgery; Fac

1970
[5-Fluorouracil and Bucky rays in the treatment of superficial basaliomas].
    Ceskoslovenska dermatologie, 1972, Volume: 47, Issue:2

    Topics: Aged; Carcinoma, Basal Cell; Fluorouracil; Humans; Methods; Middle Aged; Ointments; Skin Neoplasms

1972
Topical chemotherapy of cutaneous neoplasms.
    The Journal of the Indiana State Medical Association, 1972, Volume: 65, Issue:9

    Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Leukop

1972
[Therapeutic effects of 5-florouracil ointment on various skin diseases].
    Gan no rinsho. Japan journal of cancer clinics, 1972, Volume: 18, Issue:3

    Topics: Adolescent; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Huma

1972
A follow-up study of treatment of basal cell carcinoma with 5-fluorouracil ointment.
    Dermatologica, 1972, Volume: 144, Issue:4

    Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Follow-Up Studies; Humans; Neoplasm Recu

1972
Treatment of basal and squamous cancers of the nose and ear with 5-fluorouracil cream.
    The Laryngoscope, 1971, Volume: 81, Issue:6

    Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Ear Neoplasms; Female; Fluorouracil; Follow-U

1971
Review of a 3-year experience with topical chemotherapy and immunotherapy of superficial cutaneous neoplasms.
    Journal of surgical oncology, 1971, Volume: 3, Issue:3

    Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chlorine; Facial Neoplasms;

1971
Tumors of the skin. XII. Topical 5-Fluorouracil for epidermal neoplasms.
    Journal of surgical oncology, 1971, Volume: 3, Issue:3

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatitis; Esthetics; Female; Fluorouracil; Humans

1971
Topical chemotherapy of advanced cutaneous malignancy with 5-Fluorouracil creme.
    Journal of surgical oncology, 1971, Volume: 3, Issue:3

    Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinoma, Squamous Cell; Esthetics

1971
Topical use of 5-fluorouracil cream for skin cancer.
    Modern trends in surgery, 1971, Volume: 3

    Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Ointments; Skin Neopla

1971
[Topical therapy of superficial basalioma and senile keratoma with 5-fluorouracil].
    Ceskoslovenska dermatologie, 1971, Volume: 46, Issue:5

    Topics: Aged; Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Precancerous Conditions; Skin Neoplasm

1971
[Trials using local 5-FU therapy in precancerous states and cancer of the skin].
    Dermatologica, 1971, Volume: 142, Issue:5

    Topics: Carcinoma, Basal Cell; Fluorouracil; Follow-Up Studies; Humans; Keratosis; Ointments; Precancerous C

1971
[5-Fluorouracil in local therapy of precancerous conditions and carcinoma of the skin].
    Schweizerische medizinische Wochenschrift, 1971, Aug-28, Volume: 101, Issue:34

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratosis; Neoplasm Recurrenc

1971
[Treatment of cutaneous tumors with fluorouracil ointment].
    Harefuah, 1971, Nov-01, Volume: 81, Issue:9

    Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Keratosi

1971
Topical 5-fluorouracil: variability of effective dosage and duration of reaction.
    Journal of the American Geriatrics Society, 1971, Volume: 19, Issue:12

    Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Skin Neoplasms

1971
[Value of the use of a 5-fluorouracil ointment in the treatment of basal cell epitheliomas in the aged].
    Bulletin de la Societe francaise de dermatologie et de syphiligraphie, 1971, Volume: 78, Issue:6

    Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Ointments; Skin Neoplasms

1971
Xeroderma pigmentosum.
    Birth defects original article series, 1971, Volume: 7, Issue:8

    Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; Eyelid Neoplasms; Female;

1971
[Apropos of 40 cases of malignant tumors treated by local-regional and general chemotherapy in a surgical department].
    Journal de chirurgie, 1969, Volume: 97, Issue:3

    Topics: Adolescent; Adult; Aminopterin; Back; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemotherapy,

1969
Cytostatic and immunologic activity of 5-mercaptouracil desoxyriboside in the management of multiple superficial basal cell epitheliomas.
    Journal of medicine, 1970, Volume: 1, Issue:3

    Topics: Antimetabolites; Carcinoma, Basal Cell; Deoxyuridine; DNA, Neoplasm; Fluorouracil; Humans; Hypersens

1970
[Treatment of skin cancer].
    Journal - Oklahoma State Dental Association, 1971, Volume: 61, Issue:4

    Topics: Age Factors; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Lip Neoplasms; Male; Melanoma; Pro

1971
[Topical therapy of precancerous lesions and skin carcinomas using a 5-fluorouracil ointment].
    Hospital (Rio de Janeiro, Brazil), 1969, Volume: 76, Issue:6

    Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Fluorouracil

1969
[Synchronization of histologically normal human tissue].
    Archiv fur klinische und experimentelle Ohren- Nasen- und Kehlkopfheilkunde, 1969, Dec-22, Volume: 194, Issue:2

    Topics: Antineoplastic Agents; Autoradiography; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; DNA; DNA, N

1969
Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions.
    Cancer, 1970, Volume: 25, Issue:2

    Topics: Antigen-Antibody Reactions; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatitis; Dermatitis,

1970
[Treatment of carcinoma and precancerosis using 5-fluorouracil].
    Archiv fur klinische und experimentelle Dermatologie, 1970, Volume: 237, Issue:1

    Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratosis; Occlusive Dressings

1970
The aging skin: problems and their causes.
    Geriatrics, 1970, Volume: 25, Issue:4

    Topics: Aged; Aging; Arsenicals; Balanitis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorou

1970
[On the treatment of superficial neoplasms with 5-FU ointment. Preliminary review].
    Giornale italiano di dermatolotia. Minerva dermatologica, 1970, Volume: 45, Issue:2

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Ointments; Skin Neoplasms

1970
Summary of our trial with 5-fluorouracil (5-FU) ointment on the treatment of basal cell epithelioma and senile keratosis.
    Dermatologica, 1970, Volume: 140

    Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Ointments; Skin Neoplasms; Time Factors

1970
Comparison of the clinical and histological effects of 5-fluorouracil (5-FU) alone and of 5-FU preceded by dimethyl-sulphoxide (DMSO) on senile keratosis.
    Dermatologica, 1970, Volume: 140

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dimethyl Sulfoxide; Fluorouracil; Humans; Keratosis

1970
Effects of 5-fluorouracil (5-FU) ointment on normal and diseased skin. Histological findings and deep action.
    Dermatologica, 1970, Volume: 140

    Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Ointments; Skin Neoplasms

1970
Basal-cell carcinoma of large dimension.
    Dermatologica, 1970, Volume: 140

    Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Skin Neoplasms

1970
5-fluorouracil (5-FU) ointment in the treatment of basal cell epithelioma. Histological control over a long duration.
    Dermatologica, 1970, Volume: 140

    Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Male; Middle Ag

1970
5-fluorouracil ointment in tumors of the skin.
    Dermatologica, 1970, Volume: 140

    Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratoacanthoma; Keratosis; Male; Middle

1970
5-fluorouracil (5-FU) ointment in the treatment of benign and malignant skin lesions.
    Dermatologica, 1970, Volume: 140

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratoacanthoma; Keratosis; L

1970
Preliminary experience with 5-fluorouracil ointment in the treatment of neoplasias and precancerous lesions of the skin.
    Dermatologica, 1970, Volume: 140

    Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Neoplasm Metast

1970
Clinical and structural evaluation of the treatment of some hyperplastic and neoplastic skin diseases with 5-fluorouracil (5-FU) ointment.
    Dermatologica, 1970, Volume: 140

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Ointments; Skin Neoplasms; Ti

1970
5-fluouracil (5-FU) ointment in the treatment of skin tumours and keratoses.
    Dermatologica, 1970, Volume: 140

    Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Keratoacanthoma

1970
[Cytostatics in basalioma therapy?].
    Deutsche medizinische Wochenschrift (1946), 1970, Oct-16, Volume: 95, Issue:42

    Topics: Antimetabolites; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Ointments

1970
[Electron microscopy studies on the effect of 5-fluorouracil on basaliomas].
    Zeitschrift fur Haut- und Geschlechtskrankheiten, 1971, Aug-15, Volume: 46, Issue:16

    Topics: Back; Biopsy; Carcinoma, Basal Cell; Facial Neoplasms; Fluorouracil; Humans; Microscopy, Electron; S

1971
The treatment of skin carcinoma with podophyllum derivatives.
    The British journal of dermatology, 1971, Volume: 84, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Colchicine; Fluorouracil; Hu

1971
[Therapy of basal cell carcinoma of the skin with fluorouracil salve].
    Ugeskrift for laeger, 1968, Mar-28, Volume: 130, Issue:13

    Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Occlusive Dressings; O

1968
[Topical cytostatic treatment of epitheliomas with a 5 per cent 5-fluorouracil ointment].
    Zeitschrift fur Haut- und Geschlechtskrankheiten, 1968, Sep-15, Volume: 43, Issue:18

    Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Keratoacanthoma

1968
[Local chemotherapy in the treatment of basal cell epithelioma. 1st results obtained by topical application of 5 fluoro-uracil].
    Archives belges de dermatologie et de syphiligraphie, 1968, Volume: 24, Issue:1

    Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Occlusive Dressings; Ointments; Skin Neoplasms

1968
[Experiences with a cytostaticly active ointment in the dermatologic practice. (5 per cent--5-fluorouracil ointment)].
    Wiener medizinische Wochenschrift (1946), 1969, Mar-29, Volume: 119, Issue:13

    Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Lichen P

1969
Tumors of the skin. XI. Effect of occlusive dressing on the local administration of 5-fluorouracil to superficial basal cell carcinoma.
    The Journal of investigative dermatology, 1969, Volume: 52, Issue:3

    Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Occlusive Dressings; O

1969
Topical chemotherapy of cutaneous malignancy of the head and neck.
    Southern medical journal, 1969, Volume: 62, Issue:5

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Head and Neck Neoplasms; Humans; Kera

1969
The topical application of 5-fluorouracil in the treatment of skin lesions.
    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1969, Volume: 121, Issue:7

    Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Male; Skin Neoplasms

1969
Fluorouracil topically for skin cancer.
    JAMA, 1969, Feb-03, Volume: 207, Issue:5

    Topics: Aged; Carcinoma, Basal Cell; Fluorouracil; Humans; Keratosis; Male; Ointments; Propylene Glycols; Sk

1969
Preliminary studies in the use of 5-fluoro-uracil cream in the treatment of malignant and premalignant skin tumours.
    The Medical journal of Australia, 1969, Aug-23, Volume: 2, Issue:8

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratoacanthoma; Keratosis; O

1969